Programming – Vascular Discovery 2024
May 15–18, 2024
Hilton Chicago | Chicago, Illinois
Vascular Discovery 2024 Schedule-at-a-Glance
All times are Central Daylight Time (CDT, GMT -5)
| Time | Activity |
|---|---|
| 8:00 a.m. – 6:00 p.m. | Vascular Research Initiatives Conference(link opens in new window) This event is not part of the official Vascular Discovery Scientific Sessions as planned by the Program Committee. Separate registration is required to attend. |
| 3:00 p.m. – 7:00 p.m. | Vascular Discovery Scientific Sessions Registration |
| 6:30 p.m. – 8:00 p.m. | Poster Session 1 & Reception |
| Time | Activity |
|---|---|
| 7:00 a.m. to 8:00 a.m. | Registration, Breakfast, Exhibits |
| 7:00 a.m. to 8:00 a.m. | Early Career Training Session 1 |
| 8:00 a.m. to 8:30 a.m. |
Conference Opening Welcome 8:00 Welcome Remarks from AHA President 8:15 Welcome Remarks from the Program Chair |
| 8:30 a.m. to 10:00 a.m. |
Plenary Session 1: Hot Topics in Cardiovascular Disease 8:30 Complementing Human Organoids for Vascular Discovery 9:00 Clonal hematopoiesis, aging, and CVD 9:30 Title TBA |
| 10:00 a.m. to 10:30 a.m. | BREAK/Exhibits |
| 10:30 a.m. to 12:15 p.m. |
Concurrent Session 1a: Molecular and Cellular Mechanisms of Atherosclerosis |
| 10:30 a.m. to 12:15 p.m. | Concurrent Session 1b: Inflammation & Immunity in the Vessel Wall |
| 10:30 a.m. to 12:15 p.m. |
Concurrent Session 1c: Endothelial Dysfunction in Thrombosis 10:30 Endothelial Dysfunction in Carotid Atherothrombosis and Stroke 10:50 Regulation of Endothelial Procoagulant Activity by TMEM16 Proteins 11:10 Invited Speaker-TBD Oral Abstract Presentations |
| 12:15 p.m. to 2:00 p.m. | The Mentor of Women Award Luncheon |
| 12:15 p.m. to 2:00 p.m. | PVD Annual Business Meeting & Networking Lunch |
| 12:15 p.m. to 2:15 p.m. | Lunch on your own |
| 2:15 p.m. to 3:45 p.m. | Plenary Session 2: Highlights from the ATVB Journal |
| 3:45 p.m. to 4:15 p.m. | Break/Exhibits |
| 4:15 p.m. to 6:00 p.m. | Concurrent Session 2a: Apolipoproteins, Lipoproteins, and Lipid Metabolism |
| 4:15 p.m. to 6:00 p.m. | Concurrent Session 2b: Thrombosis: Signaling, Mechanisms and Function |
| 4:15 p.m. to 6:00 p.m. | Concurrent Session 2c: Investigator in Training Award Oral Abstract Competition and Hot Off The Bench Oral Abstract Presentations |
| 6:00 p.m to 7:30 p.m. |
Poster Session 2 & Reception |
| Time | Activity |
|---|---|
| 7:00 a.m. | Registration, Breakfast & Exhibits |
| 7:00 a.m. to 8:00 a.m. | Early Career Training Session 2 |
| 8:00 a.m. to 9:30 a.m. |
Plenary Session 3: Advances in Cardiometabolic Disease 8:00 Presentation title TBA 8:30 Presentation title TBA 9:00 Gut Bacterial Metabolism and Cardiometabolic Disease |
| 9:30 a.m. to 10:00 a.m. | BREAK/Exhibits |
| 10:00 a.m. to 11:45 a.m. | Concurrent Session 3a: Therapeutic Targets in Atherosclerosis |
| 10:00 a.m. to 11:45 a.m. | Concurrent Session 3b: Blood Coagulation in Health & Disease |
| 10:00 a.m. to 11:45 a.m. |
Concurrent Session 3c: Carotid Artery Disease 10:00 Presentation title TBA 10:20 Presentation title TBA 10:40 Exploring Carotid Plaque Instability: a BIKE-ride from Identification of Molecular Disease Targets to Improved Stroke-risk Prediction 11:00 Endothelial Dysfunction in Carotid Atherothrombosis and Stroke 11:20 Oral Abstract Presentations |
| 11:45 a.m. to 12:45 p.m. | Building Inclusive Mentoring Relationships (Presented by the ATVB Diversity Committee) |
| 11:45. a.m. to 1:45 p.m. | Lunch on your own |
| 1:45 p.m. to 3:45 p.m. | Plenary Session 4: Early Career Investigator Award Competition Brinkhous Prize and Page Jr Faculty Research Award |
| 3:45 p.m. to 4:15 p.m. | Break/Exhibits |
| 4:15 p.m to 6:00 p.m. | Concurrent Session 4a: Metabolic Disorders in Atherosclerosis |
| 4:15 p.m to 6:00 p.m. |
Concurrent Session 4b: Vascular Cells, Inflammation and Thrombosis |
| 4:15 p.m to 6:00 p.m. | Concurrent Session 4c: Genomics and Multi-Omics in Vascular Disease |
| 6:00 p.m. to 7:30 p.m. |
Poster Session 3 and Reception |
| Time | Activity |
|---|---|
| 7:00 a.m. to 8:30 a.m. | Continental Breakfast |
| 8:30 a.m. to 10:00 a.m. |
Plenary Session 5: Cardio-oncology: The Role of the Vasculature 8:30 Cardio-oncology Through a Vascular Lens 9:00 Anthracycline Chemotherapy-mediated Vascular Dysfunction: Understanding Basic Mechanisms to Inform Future Clinical Therapies 9:30 Presentation title TBA Oral Abstract Presentation |
| 10:00 a.m. to 10:15 a.m. | BREAK/Exhibits |
| 10:15 a.m. to 12:15 p.m. |
Plenary Session 6: Invited Lecture Series 10:15 Hoeg Award Lecture 10:45 Keynote Lecture 11:15 Distinguished Lecture: Targets for New Anticoagulants: XI Before XII 11:45 PVD Mid-Career Award Lecture |
| 12:15 p.m. | Closing Remarks |
About this Meeting
This 2 ½-day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology, the Peripheral Vascular Disease Council, and the Council on Genomic and Precision Medicine, in cooperation with and the Society for Vascular Surgery's Vascular Research Initiatives Conference.
Vascular Discovery 2024 will provide unique opportunities to meet with colleagues from around the world with wide-ranging research interests and expertise for the timely exchange of information about new and emerging scientific research in the areas of arteriosclerosis, thrombosis and vascular biology, peripheral vascular disease, vascular surgery research, genomics and precision medicine. We expect a broad representation from many disciplines and encourage young scientists to attend.
See the American Heart Association Policies and Guiding Values (PDF).
Target Audience
The conference will especially appeal to scientists and clinicians interested in:
- Allergy and Immunology
- Arteriosclerosis
- Biochemistry
- Biological Sciences
- Diabetes and Metabolism
- Functional Genomics
- Genetics
- Hematology
- Internal Medicine
- Molecular/Cellular Biology
- Nutrition
- Pathology
- Peripheral Artery Disease
- Pharmacology
- Physiology
- Vascular Surgery
- Thrombosis
- Vascular Biology
- Vascular Medicine
Vascular Discovery 2024
Keynote Lecture and Distinguished Lecture Speakers
Keynote Lecture
Kristy Red-Horse, PhD
Howard Hughes Medical Institute / Stanford University
Invited Lecture Series
Presentation Title: TBD
Kristy Red-Horse is a Professor at Stanford University’s Department of Biology and Institute for Stem Cell Biology & Regenerative Medicine. She is also an Investigator with the Howard Hughes Medical Institute. Her PhD research explored how the vasculature of the placenta incorporates within the uterine arterial network. As a postdoc at Stanford, Dr. Red-Horse identified the progenitors of coronary arteries in mouse hearts. In her own lab, she and her team went on to explore many different aspects of how coronary arteries develop from these progenitors. The Red-Horse group also studies how coronaries regenerate and respond to injury, and devises methods for increasing their growth to enhance cardiac recovery. Dr. Red-Horse has received awards such as the NIH Pathway to Independence Award (K99/R00) and the Searle Scholar’s Award. She was also a New York Stem Cell Foundation—Robertson Investigator and received the Judah Folkman Award in vascular biology. In 2021, Dr. Red-Horse was named a Howard Hughes Investigator. In 2023, Dr. Red-Horse became a member of the National Academy of Medicine.
Distinguished Lecture
Jeffrey Weitz, MD, FAHA, FRCPC, FRSC, FACP
McMaster University
Thrombosis & Atherosclerosis Research Institute
Invited Lecture Series
Presentation Title: Targets for new anticoagulants: XI before XII
Dr. Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University, Executive Director of the Thrombosis and Atherosclerosis Research Institute and Past President of Council for the International Society on Thrombosis and Haemostasis. Board Certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Weitz focuses his clinical practice on patients with thrombotic disorders. His research spans the spectrum from basic studies in the biochemistry of blood coagulation and fibrinolysis to animal models of thrombosis and on to clinical trials of antithrombotic therapy. The breadth of his work is highlighted by his over 640 publications in journals as diverse as the Journal of Clinical Investigation, Journal of Biological Chemistry, Biochemistry, Circulation, Blood, Annals of Internal Medicine, New England Journal of Medicine and Lancet, and 76 book chapters. The recipient of numerous awards, Dr. Weitz was appointed as an Officer of the Order of Canada and is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences.
Vascular Discovery 2024
Invited Speakers
Carl Ade, PhD
Kansas State University
Cardio-oncology: the Role of the Vasculature
Presentation Title: TBD
Zoltan Arany, MD, PhD
University of Pennsylvania
Advances in Cardiometabolic Disease
Presentation Title: TBD
Zachary Clayton, PhD
University of Colorado Boulder
Cardio-oncology: the Role of the Vasculature
Presentation Title: Anthracycline chemotherapy-mediated vascular dysfunction: Understanding basic mechanisms to inform future clinical therapies
Santhi Ganesh, MD
University of Michigan
Carotid Artery Disease
Presentation Title: TBD
Courtney Griffin, PhD
Oklahoma Medical Research Foundation
Endothelial Dysfunction in Thrombosis
Presentation Title: Genetic analysis of endothelial protease-activated receptors in disease contexts
Ulf Hedin, MD, PhD
Karolinska University Hospital & Karolinska Institute
Carotid Artery Disease
Presentation Title: Exploring carotid plaque instability: a BiKE-ride from identification of molecular disease targets to improved stroke-risk prediction
Kathryn L Howe, MD, PhD, FRCSC
University Health Network, Peter Munk Cardiac Centre
Carotid Artery Disease
Presentation Title: Endothelial Dysfunction in Carotid Atherothrombosis and Stroke
Iris Jaffe, MD, PhD
Tufts Medical Center
Cadio-oncology the Role of the Vasculature
Presentation Title: Cardio-oncology Through a Vascular Lens
Minna Kaikkonen, PhD
A.I.Virtanen Institute, University of Eastern Finland
Hot Topics in Cardiovascular Disease
Presentation Title: TBD
Ruth McPherson, MD, PhD, FRCPC
University of Ottawa Heart Institute
Advances in Cardiometabolic Disease
Presentation Title: TBD
Federico E. Rey, PhD
University of Wisconsin – Madison
Advances in Cardiometabolic Disease
Presentation Title: Gut Bacterial Metabolism and Cardiometabolic Disease
Alec A. Schmaier, MD, PhD
Beth Israel Deaconess Medical Center
Endothelial Dysfunction in Thrombosis
Presentation Title: Regulation of endothelial procoagulant activity by TMEM16 proteins
Takanori Takebe, MD, PhD
Cincinnati Children’s Hospital Medical Center
Hot Topics in Cardiovascular Disease
Presentation Title: Complementing Human Organoids for Vascular Discovery
Kenneth Walsh, PhD
University of Virginia
Hot Topics in Cardiovascular Disease
Presentation Title: Clonal Hematopoiesis, Aging, and CVD
Wei Zhou, MD
University of Arizona
Carotid Artery Disease
Presentation Title: TBD
Programming from 2023
- Vascular Discovery 2023 abstracts published in ATVB journal
- Online Program Planner (link opens in new window)(link opens in new window)(link opens in new window)
- Final Program (PDF, 9.8MB)
- 2023 Vascular Discovery Awardees (PDF)
- 2023 Poster Presentations (PDF, 30 MB) - use Online Program Planner to see full abstract text
- 2023 Invited Lecturers Brochure (PDF)
- 2023 Room Locator (PDF)